These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8450054)

  • 1. Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema.
    Kramer J; Rosen FS; Colten HR; Rajczy K; Strunk RC
    J Clin Invest; 1993 Mar; 91(3):1258-62. PubMed ID: 8450054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.
    Kramer J; Katz Y; Rosen FS; Davis AE; Strunk RC
    J Clin Invest; 1991 May; 87(5):1614-20. PubMed ID: 1902490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema.
    Cicardi M; Igarashi T; Rosen FS; Davis AE
    J Clin Invest; 1987 Mar; 79(3):698-702. PubMed ID: 3818946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with a duplication in exon 8.
    Ernst SC; Circolo A; Davis AE; Gheesling-Mullis K; Fliesler M; Strunk RC
    J Immunol; 1996 Jul; 157(1):405-10. PubMed ID: 8683145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon.
    Ariga T; Igarashi T; Ramesh N; Parad R; Cicardi M; Davis AE
    J Clin Invest; 1989 Jun; 83(6):1888-93. PubMed ID: 2723063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.
    Quastel M; Harrison R; Cicardi M; Alper CA; Rosen FS
    J Clin Invest; 1983 Apr; 71(4):1041-6. PubMed ID: 6833491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema.
    Cicardi M; Igarashi T; Kim MS; Frangi D; Agostoni A; Davis AE
    J Clin Invest; 1987 Dec; 80(6):1640-3. PubMed ID: 2890659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary and acquired deficiencies of C1 inhibitor.
    Davis AE
    Immunodefic Rev; 1989; 1(3):207-26. PubMed ID: 2698641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.
    Cugno M; Nuijens J; Hack E; Eerenberg A; Frangi D; Agostoni A; Cicardi M
    J Clin Invest; 1990 Apr; 85(4):1215-20. PubMed ID: 2318974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paternal mosaicism and hereditary angioedema in a Taiwanese family.
    Yu TC; Shyur SD; Huang LH; Wen DC; Li JS
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):375-9. PubMed ID: 17941288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A de novo deletion in the C1 inhibitor gene in a case of sporadic hereditary angioneurotic edema.
    Ariga T; Hoshioka A; Kohno Y; Sakamaki T; Matsumoto S
    Clin Immunol Immunopathol; 1993 Oct; 69(1):103-5. PubMed ID: 8403537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1 inhibitor gene expression in patients with hereditary angioedema: quantitative evaluation by means of real-time RT-PCR.
    Pappalardo E; Zingale LC; Cicardi M
    J Allergy Clin Immunol; 2004 Sep; 114(3):638-44. PubMed ID: 15356570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site.
    Parad RB; Kramer J; Strunk RC; Rosen FS; Davis AE
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6786-90. PubMed ID: 2118657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema.
    Davis AE; Bissler JJ; Cicardi M
    Behring Inst Mitt; 1993 Dec; (93):313-20. PubMed ID: 8172583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1-inhibitor--biochemical properties and clinical applications.
    Al-Abdullah IH; Greally J
    Crit Rev Immunol; 1985; 5(4):317-30. PubMed ID: 3899511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of C1 inhibitor synthesis.
    Prada AE; Zahedi K; Davis AE
    Immunobiology; 1998 Aug; 199(2):377-88. PubMed ID: 9777421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol.
    Pappalardo E; Zingale LC; Cicardi M
    Immunol Lett; 2003 May; 86(3):271-6. PubMed ID: 12706530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1-inhibitor in hereditary angioneurotic edema: types I and II.
    Donaldson VH
    Behring Inst Mitt; 1989 Jul; (84):151-60. PubMed ID: 2679530
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema.
    Frangi D; Cicardi M; Sica A; Colotta F; Agostoni A; Davis AE
    J Clin Invest; 1991 Sep; 88(3):755-9. PubMed ID: 1885769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.
    Donaldson VH; Harrison RA; Rosen FS; Bing DH; Kindness G; Canar J; Wagner CJ; Awad S
    J Clin Invest; 1985 Jan; 75(1):124-32. PubMed ID: 3965500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.